Log in

OTCMKTS:CVLB - Conversion Labs Stock Price, Forecast & News

$0.14
0.00 (0.00 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$0.12
Now: $0.14
$0.14
50-Day Range
$0.11
MA: $0.13
$0.15
52-Week Range
$0.08
Now: $0.14
$0.20
Volume40,249 shs
Average Volume34,802 shs
Market Capitalization$7.48 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81
Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Sub-IndustryN/A
SectorRetail/Wholesale
Current SymbolOTCMKTS:CVLB
CUSIPN/A
CIKN/A
Phone866-351-5907

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.32 million
Book Value$0.02 per share

Profitability

Net Income$-1,240,000.00

Miscellaneous

Employees16
Market Cap$7.48 million
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable

Receive CVLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CVLB and its competitors with MarketBeat's FREE daily newsletter.


Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB."

When is Conversion Labs' next earnings date?

Conversion Labs is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Conversion Labs.

Has Conversion Labs been receiving favorable news coverage?

News articles about CVLB stock have trended somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Conversion Labs earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Conversion Labs.

Who are some of Conversion Labs' key competitors?

What other stocks do shareholders of Conversion Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Conversion Labs investors own include AXT (AXTI), Alteryx (AYX), AVEO Pharmaceuticals (AVEO), Icahn Enterprises (IEP), Lam Research (LRCX), Mellanox Technologies (MLNX), Skyworks Solutions (SWKS), Viper Energy Partners (VNOM), Brookfield Infrastructure Partners (BIP) and BP (BP).

Who are Conversion Labs' key executives?

Conversion Labs' management team includes the folowing people:
  • Mr. Justin Schreiber, CEO, Pres & Director (Age 36)
  • Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)
  • Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)
  • Mr. Robert Kalkstein, Advisor to the CEO (Age 37)
  • Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36)

How do I buy shares of Conversion Labs?

Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $0.14.

How big of a company is Conversion Labs?

Conversion Labs has a market capitalization of $7.48 million and generates $8.32 million in revenue each year. Conversion Labs employs 16 workers across the globe.View Additional Information About Conversion Labs.

What is Conversion Labs' official website?

The official website for Conversion Labs is http://www.conversionlabs.com/.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 866-351-5907 or via email at ir.conversionlabs.com.


MarketBeat Community Rating for Conversion Labs (OTCMKTS CVLB)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  111 (Thanks for Voting!)
Underperform Votes:  117 (Thanks for Voting!)
Total Votes:  228
MarketBeat's community ratings are surveys of what our community members think about Conversion Labs and other stocks. Vote "Outperform" if you believe CVLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Trading Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel